{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:02:36Z","timestamp":1784649756054,"version":"3.55.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Aminoglycoside-mediated readthrough offers a targeted strategy to restore type VII collagen in recessive dystrophic epidermolysis bullosa caused by COL7A1 nonsense mutations. Systemic gentamicin was safe and produced notable but reversible clinical improvement in paediatric patients.<\/jats:p>","DOI":"10.1093\/ced\/llag263","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:38:42Z","timestamp":1781955522000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa with nonsense\n                    <i>COL7A1<\/i>\n                    mutations"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-719X","authenticated-orcid":false,"given":"Pablo","family":"Lopez Balboa","sequence":"first","affiliation":[{"name":"Paediatric Dermatology Department, Great Ormond Street Hospital NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L","family":"Bageta","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department, Great Ormond Street Hospital NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Alauddin","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department, Great Ormond Street Hospital NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8113-0373","authenticated-orcid":false,"given":"Gabriela","family":"Petrof","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department, Great Ormond Street Hospital NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E","family":"Martinez","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department, Great Ormond Street Hospital NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2026072111063231100_llag263-B1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"2026072111063231100_llag263-B2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","article-title":"Readthrough compounds for nonsense mutations: bridging the translational gap","volume":"29","author":"Spelier","year":"2023","journal-title":"Trends Mol Med"},{"key":"2026072111063231100_llag263-B3","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J Clin Invest"},{"key":"2026072111063231100_llag263-B4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/bjd\/ljae063","article-title":"Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial","volume":"191","author":"Woodley","year":"2024","journal-title":"Br J Dermatol"},{"key":"2026072111063231100_llag263-B5","doi-asserted-by":"crossref","first-page":"102334","DOI":"10.1016\/j.omtn.2024.102334","article-title":"Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa","volume":"35","author":"Levian","year":"2024","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag263\/68582284\/llag263.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag263\/68582284\/llag263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:06:38Z","timestamp":1784646398000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag263\/8713619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag263","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"llag263"}}